COSAN SA -ADR (CSAN) Fundamental Analysis & Valuation

NYSE:CSAN • US22113B1035

Current stock price

4.09 USD
-0.21 (-4.88%)
At close:
4.09 USD
0 (0%)
After Hours:

This CSAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CSAN Profitability Analysis

1.1 Basic Checks

  • In the past year CSAN has reported negative net income.
  • CSAN had a positive operating cash flow in the past year.
  • CSAN had positive earnings in 4 of the past 5 years.
  • CSAN had a positive operating cash flow in each of the past 5 years.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

  • The Return On Assets of CSAN (-10.51%) is worse than 74.19% of its industry peers.
  • With a Return On Equity value of -223.96%, CSAN is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
  • CSAN has a better Return On Invested Capital (6.65%) than 64.52% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CSAN is significantly below the industry average of 13.59%.
  • The last Return On Invested Capital (6.65%) for CSAN is above the 3 year average (4.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -10.51%
ROE -223.96%
ROIC 6.65%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

  • CSAN has a better Operating Margin (21.91%) than 98.39% of its industry peers.
  • CSAN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CSAN (31.95%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CSAN has remained more or less at the same level.
Industry RankSector Rank
OM 21.91%
PM (TTM) N/A
GM 31.95%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CSAN Health Analysis

2.1 Basic Checks

  • CSAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CSAN has less shares outstanding
  • CSAN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CSAN is higher compared to a year ago.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

  • CSAN has an Altman-Z score of 0.76. This is a bad value and indicates that CSAN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.76, CSAN is doing worse than 70.97% of the companies in the same industry.
  • CSAN has a debt to FCF ratio of 15.31. This is a negative value and a sign of low solvency as CSAN would need 15.31 years to pay back of all of its debts.
  • The Debt to FCF ratio of CSAN (15.31) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 10.57 is on the high side and indicates that CSAN has dependencies on debt financing.
  • CSAN's Debt to Equity ratio of 10.57 is on the low side compared to the rest of the industry. CSAN is outperformed by 78.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.57
Debt/FCF 15.31
Altman-Z 0.76
ROIC/WACC0.94
WACC7.06%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • CSAN has a Current Ratio of 1.80. This is a normal value and indicates that CSAN is financially healthy and should not expect problems in meeting its short term obligations.
  • CSAN has a Current ratio of 1.80. This is in the better half of the industry: CSAN outperforms 76.61% of its industry peers.
  • CSAN has a Quick Ratio of 1.65. This is a normal value and indicates that CSAN is financially healthy and should not expect problems in meeting its short term obligations.
  • CSAN's Quick ratio of 1.65 is amongst the best of the industry. CSAN outperforms 86.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.65
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CSAN Growth Analysis

3.1 Past

  • The earnings per share for CSAN have decreased strongly by -723.51% in the last year.
  • CSAN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.36%.
  • CSAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.51% yearly.
EPS 1Y (TTM)-723.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-18.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.37% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 1.71% on average over the next years.
EPS Next Y72%
EPS Next 2Y48.48%
EPS Next 3Y33.37%
EPS Next 5YN/A
Revenue Next Year-3.69%
Revenue Next 2Y-0.82%
Revenue Next 3Y0.9%
Revenue Next 5Y1.71%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

6

4. CSAN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSAN. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 15.45, CSAN is valued correctly.
  • Based on the Price/Forward Earnings ratio, CSAN is valued a bit cheaper than 68.55% of the companies in the same industry.
  • CSAN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE N/A
Fwd PE 15.45
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • CSAN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CSAN is cheaper than 85.48% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CSAN is valued cheaply inside the industry as 91.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.76
EV/EBITDA 5.27
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • CSAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CSAN's earnings are expected to grow with 33.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.48%
EPS Next 3Y33.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CSAN Dividend Analysis

5.1 Amount

  • CSAN has a Yearly Dividend Yield of 2.44%.
  • CSAN's Dividend Yield is rather good when compared to the industry average which is at 2.51. CSAN pays more dividend than 80.65% of the companies in the same industry.
  • CSAN's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

  • On average, the dividend of CSAN grows each year by 25.09%, which is quite nice.
  • CSAN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)25.09%
Div Incr Years0
Div Non Decr Years0
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

  • CSAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • CSAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-18.65%
EPS Next 2Y48.48%
EPS Next 3Y33.37%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

More info and screens

Find the best dividend stocksShow peers with best dividend

CSAN Fundamentals: All Metrics, Ratios and Statistics

COSAN SA -ADR

NYSE:CSAN (3/13/2026, 8:18:45 PM)

After market: 4.09 0 (0%)

4.09

-0.21 (-4.88%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-03
Earnings (Next)05-14
Inst Owners13.17%
Inst Owner Change39.06%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.05B
Revenue(TTM)43.95B
Net Income(TTM)-13.22B
Analysts78.89
Price Target4.8 (17.36%)
Short Float %0.27%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.67
Dividend Growth(5Y)25.09%
DP-18.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-457.66%
Min EPS beat(2)-596.78%
Max EPS beat(2)-318.54%
EPS beat(4)0
Avg EPS beat(4)-807.14%
Min EPS beat(4)-1285.85%
Max EPS beat(4)-318.54%
EPS beat(8)1
Avg EPS beat(8)-403.23%
EPS beat(12)2
Avg EPS beat(12)-280.22%
EPS beat(16)3
Avg EPS beat(16)-219.16%
Revenue beat(2)0
Avg Revenue beat(2)-74.11%
Min Revenue beat(2)-74.75%
Max Revenue beat(2)-73.47%
Revenue beat(4)0
Avg Revenue beat(4)-74.86%
Min Revenue beat(4)-76.92%
Max Revenue beat(4)-73.47%
Revenue beat(8)0
Avg Revenue beat(8)-64.68%
Revenue beat(12)0
Avg Revenue beat(12)-51.61%
Revenue beat(16)0
Avg Revenue beat(16)-57.62%
PT rev (1m)0%
PT rev (3m)-20.85%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)4.49%
EPS NY rev (1m)-1.57%
EPS NY rev (3m)-55.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.22%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.45
P/S 0.49
P/FCF 4.76
P/OCF 1.56
P/B 3.54
P/tB N/A
EV/EBITDA 5.27
EPS(TTM)-1.29
EYN/A
EPS(NY)0.26
Fwd EY6.47%
FCF(TTM)0.86
FCFY21.03%
OCF(TTM)2.62
OCFY64%
SpS8.33
BVpS1.15
TBVpS-4.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.51%
ROE -223.96%
ROCE 8.42%
ROIC 6.65%
ROICexc 7.79%
ROICexgc 10.81%
OM 21.91%
PM (TTM) N/A
GM 31.95%
FCFM 10.32%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
ROICexc(3y)5.12%
ROICexc(5y)5.21%
ROICexgc(3y)6.64%
ROICexgc(5y)7.56%
ROCE(3y)5.52%
ROCE(5y)5.33%
ROICexgc growth 3Y5.58%
ROICexgc growth 5Y-20.62%
ROICexc growth 3Y6.6%
ROICexc growth 5Y-13.61%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 10.57
Debt/FCF 15.31
Debt/EBITDA 4.71
Cap/Depr 228.56%
Cap/Sales 21.09%
Interest Coverage 1.82
Cash Conversion 100.88%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.65
Altman-Z 0.76
F-Score5
WACC7.06%
ROIC/WACC0.94
Cap/Depr(3y)179.81%
Cap/Depr(5y)178.28%
Cap/Sales(3y)15.09%
Cap/Sales(5y)13.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-723.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y72%
EPS Next 2Y48.48%
EPS Next 3Y33.37%
EPS Next 5YN/A
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-18.3%
Revenue Next Year-3.69%
Revenue Next 2Y-0.82%
Revenue Next 3Y0.9%
Revenue Next 5Y1.71%
EBIT growth 1Y77.24%
EBIT growth 3Y24.77%
EBIT growth 5Y21.84%
EBIT Next Year96.25%
EBIT Next 3Y32.07%
EBIT Next 5Y16.36%
FCF growth 1Y-12.14%
FCF growth 3Y65.47%
FCF growth 5Y21.36%
OCF growth 1Y24.78%
OCF growth 3Y35.81%
OCF growth 5Y36.03%

COSAN SA -ADR / CSAN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSAN.


What is the valuation status for CSAN stock?

ChartMill assigns a valuation rating of 6 / 10 to COSAN SA -ADR (CSAN). This can be considered as Fairly Valued.


How profitable is COSAN SA -ADR (CSAN) stock?

COSAN SA -ADR (CSAN) has a profitability rating of 4 / 10.


What is the earnings growth outlook for COSAN SA -ADR?

The Earnings per Share (EPS) of COSAN SA -ADR (CSAN) is expected to grow by 72% in the next year.